Antiherpetic medication and incident dementia: Observational cohort studies in four countries
Open accessPublished version of a preprint
Abstract
Background and purpose: Several epidemiological studies from Taiwan, all using the same data resource, found significant associations between herpes virus infection, antiherpetic medication, and subsequent dementia. We conducted a multicenter observational cohort study using health registry data from Wales, Germany, Scotland, and Denmark to investigate potential associations between antiherpetic medication and incident dementia, and also to comprehensively investigate such associations broken down according to medication type and dose, type of herpes virus, and dementia subtype. Methods: A total of 2.5 million individuals aged 65 years or more were followed up using linked electronic health records in four national observational cohort studies. Exposure and outcome were classified using coded data from primary and secondary care. Data were analyzed using survival analysis with time‐dependent covariates. Results: Results were heterogeneous, with a tendency toward decreased dementia risk in individuals exposed to antiherpetic medication. Associations were not affected by treatment number, herpes subtype, dementia subtype, or specific medication. In one cohort, individuals diagnosed with herpes but not exposed to antiherpetic medication were at higher dementia risk. Conclusions: Short‐term antiherpetic medication is not markedly associated with incident dementia. Because neither dementia subtype nor herpes subtype modified the association, the small but significant decrease in dementia incidence with antiherpetic administration may reflect confounding and misclassification.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies using electronic health records have found a link between VZV and risk of all-cause dementia, AD, vascular dementia, with antivirals decreasing all-cause dementia risk.
“Studies using electronic health records have found a link between VZV and risk of all-cause dementia, AD, vascular dementia, with antivirals decreasing all-cause dementia risk [23,36–40].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [38]
The Introduction reports studies linking VZV infection to incident dementia, and the Dementia incidence results find a small association between antiherpetic medication and lower dementia incidence in some cohorts. The paper does not establish a VZV-specific link to Alzheimer disease or vascular dementia: its findings for those subtypes concern medication exposure, not VZV infection. It also cautions in the Discussion that the medication association was heterogeneous and may reflect confounding, rather than a demonstrated reduction caused by antivirals. Page numbers were not provided in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The SAIL databank: linking multiple health and social care datasets
Lyons, R. A., Jones, K. H., John, G., Brooks, C. J., Verplancke, J.-P., Ford, D. V., Brown, G., & Leake, K. (2009) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-9-3 · Cited by 638 · see citing works
Tzeng, N.-S., Chung, C.-H., Lin, F.-H., Chiang, C.-P., Yeh, C.-B., Huang, S.-Y., Lu, R.-B., Chang, H.-A., Kao, Y.-C., Yeh, H.-W., et al. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0611-x · Cited by 356 · see citing works
Validity of Dementia Diagnoses in the Danish Hospital Registers
Phung, T. K. T., Andersen, B. B., Høgh, P., Kessing, L. V., Mortensen, P. B., & Waldemar, G. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107084 · Cited by 279 · see citing works
Self-citationHerpes Zoster and Dementia: A Nationwide Population-Based Cohort Study
Chen, V. C.-H., Wu, S.-I., Huang, K.-Y., Yang, Y.-H., Kuo, T.-Y., Liang, H.-Y., Huang, K.-L., & Gossop, M. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11312 · Cited by 142 · cited 1× · see citing works
“1) compared to controls [7], and the subgroup who were treated with antiherpetic medication had a reduced risk of dementia (HR = 0.”
Background
Flagged first, then by citations
Research works printed but not linked: 18
- Abbott A. Are infections seeding some cases of Alzheimer's dis- ease? Nature. 2020;587(7832):22-25.
- Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ϵ4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43(8):1467-1472.
- Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 1997;349(9047):241-244.
- Powell-Doherty RD, Abbott ARN, Nelson LA, Bertke AS. Amyloid-β and p-Tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons. J Virol. 2020;94(9): e01874-19.
- Bubak AN, Beseler C, Como CN, et al. Amylin, Aβ42, and amyloid in varicella zoster virus vasculopathy cerebrospinal fluid and infected vascular cells. J Infect Dis. 2020. https://doi.org/10.1093/infdi s/ jiaa513. · DOI
- Tsai MC, Cheng WL, Sheu JJ, et al. Increased risk of dementia follow- ing herpes zoster ophthalmicus. PLoS One. 2017;12(11):e0188490.
- Bae S, Yun S-C, Kim M-C, et al. Association of herpes zoster with de- mentia and effect of antiviral therapy on dementia: a population-based cohort study. European Archives of Psychiatry and Clinical Neuroscience. 2020;http://dx.doi.org/10.1007/s0040 6-020-01157 -4. · DOI · Paper page
- Warren-Gash C, Forbes HJ, Williamson E, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019;9(1):4743.
- Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459-466.
- Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7):22-25.
- Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490.
- Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish na- tional prescription registry. Scand J Public Health. 2011;39(7):38-41.
- Hagger-Johnson G. Opportunities for longitudinal data linkage in Scotland. Scott Med J. 2016;61(3):136-145.
- Wilkinson T, Schnier C, Bush K, et al. Identifying dementia out- comes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557-565.
- Friedman M. Piecewise exponential models for survival data with covariates. Ann Stat. 1982;10(1):101-113.
- Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribu- tion in the world. Is APOE * 4 a 'thrifty' allele? Ann Hum Genet. 1999;63(4):301-310.
- Pincus T, Callahan LF. What explains the association between so- cioeconomic status and health: primarily access to medical care or mind-body variables? Advances. 1995;11(1):4-36.
- Wilkinson T, Schnier C, Bush K, Hutchison A, Rannikmäe K, Sudlow C. P1-559: drug prescriptions and dementia incidence: a medication-wide association study. Alzheimer's Dement. 2019;15:P488-P489.
Cited by
Sorted by citations
Duggan, M. R., Peng, Z., An, Y., Kitner Triolo, M. H., Shafer, A. T., Davatzikos, C., Erus, G., Karikkineth, A., Lewis, A., Moghekar, A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201036 · Cited by 24 · see citing works
Warren‐Gash, C., Cadogan, S. L., Nicholas, J. M., Breuer, J. M., Shah, D., Pearce, N., Shiekh, S., Smeeth, L., Farlow, M. R., Mori, H., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51669 · Cited by 11 · see citing works
What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease?
Brutkiewicz, R. R., Cao, W., Morgan, D., Reis, R. S. D., Suryadevara, V., Willette, A. A., Willette, S. A., Wyatt-Johnson, S. K., & Duggan, M. R. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.05.009 · Cited by 3 · see citing works
- Authors
- Schnier, C., Janbek, J., Williams, L., Wilkinson, T., Laursen, T. M., Waldemar, G., Richter, H., Kostev, K., Lathe, R., & G Haas, J.
- Affiliations
- University of Edinburgh (GB)
- University of Copenhagen (DK)
- Aarhus University (DK)
- IQVIA (United Kingdom) (GB)
- Division of Infection Medicine University of Edinburgh Edinburgh United Kingdom
- Corresponding author
- Schnier, Christian
- ORCID
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2021-03-19
- Volume
- 28
- Issue
- 6
- Pages
- 1840-1848
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W3134069256
- Cited by
- 52
- References
- 4
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 16 · 2023: 6 · 2022: 10 · 2021: 5
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Neurology (publishedVersion, cc-by-nc)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Benter Foundation
- Medical Research Council (MR/P011349/1)
- Biotechnology and Biological Sciences Research Council (BB/K003801/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- dementia, herpesvirus infection, herpes simplex virus, antiviral agents, dementia risk, dementia subtypes, confounding, misclassification, older adults
- MeSH terms
- Dementia, Herpesviridae Infections, Humans, Registries, Risk Factors, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review